E

Emcure Pharmaceuticals Ltd
NSE:EMCURE

Watchlist Manager
Emcure Pharmaceuticals Ltd
NSE:EMCURE
Watchlist
Price: 1 357.8 INR 1.83% Market Closed
Market Cap: 256.8B INR
Have any thoughts about
Emcure Pharmaceuticals Ltd?
Write Note

Emcure Pharmaceuticals Ltd
Pre-Tax Income

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Emcure Pharmaceuticals Ltd
Pre-Tax Income Peer Comparison

Comparables:
DRREDDY
CIPLA
SUNPHARMA
T
TORNTPHARM
M
MANKIND

Competitive Pre-Tax Income Analysis
Latest Figures & CAGR of Competitors

Company Pre-Tax Income CAGR 3Y CAGR 5Y CAGR 10Y
E
Emcure Pharmaceuticals Ltd
NSE:EMCURE
Pre-Tax Income
â‚ą7.3B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Dr Reddy's Laboratories Ltd
NSE:DRREDDY
Pre-Tax Income
â‚ą72.3B
CAGR 3-Years
42%
CAGR 5-Years
22%
CAGR 10-Years
N/A
Cipla Ltd
NSE:CIPLA
Pre-Tax Income
â‚ą61.3B
CAGR 3-Years
20%
CAGR 5-Years
22%
CAGR 10-Years
15%
Sun Pharmaceutical Industries Ltd
NSE:SUNPHARMA
Pre-Tax Income
â‚ą128.4B
CAGR 3-Years
22%
CAGR 5-Years
18%
CAGR 10-Years
5%
T
Torrent Pharmaceuticals Ltd
NSE:TORNTPHARM
Pre-Tax Income
â‚ą25.8B
CAGR 3-Years
15%
CAGR 5-Years
30%
CAGR 10-Years
9%
M
Mankind Pharma Ltd
NSE:MANKIND
Pre-Tax Income
â‚ą24B
CAGR 3-Years
12%
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Emcure Pharmaceuticals Ltd's Pre-Tax Income?
Pre-Tax Income
7.3B INR

Based on the financial report for Mar 31, 2024, Emcure Pharmaceuticals Ltd's Pre-Tax Income amounts to 7.3B INR.

What is Emcure Pharmaceuticals Ltd's Pre-Tax Income growth rate?
Pre-Tax Income CAGR 1Y
-3%

Over the last year, the Pre-Tax Income growth was -3%.

Back to Top